Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]
Ascendis Pharma A/S - American Depositary Shares (ASND)
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ascendispharma.com
Company Research
Source: Seeking Alpha
Ascendis Pharma A/S (NASDAQ: ASND ) Q3 2018 Results Earnings Conference Call November 28, 2018 4:30 PM ET Executives Jan Mikkelsen - President and CEO Scott Smith - CFO Dr. Jonathan Leff - Chief Medical Officer Analysts Michelle Gilson - Canaccord Genuity Jim Birchenough - Wells Fargo Securities Jessica Fye - JP Morgan Liana Moussatos - Wedbush Securities Adam Walsh - Stifel Tiago Fauth - Credit Suisse Joseph Schwartz - Leerink Partners Operator Good day ladies and gentlemen, and welcome to the Q3 2018 Ascendis Pharma Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will host a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call may be recorded for replay purposes. It is now pleasure to hand the conference over to Mr. Scott Smith, Chief Financial Officer. Sir you may begin. Sco
Show less
Read more
Impact Snapshot
Event Time:
ASND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASND alerts
High impacting Ascendis Pharma A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ASND
News
- Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
- Ascendis Pharma A/S (ASND) Rose on Positive Trial Results [Yahoo! Finance]Yahoo! Finance
- VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China [Yahoo! Finance]Yahoo! Finance
- VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in ChinaPR Newswire
- Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024GlobeNewswire
ASND
Earnings
- 2/7/24 - Beat
ASND
Sec Filings
- 3/27/24 - Form 6-K
- 3/14/24 - Form 6-K
- 3/7/24 - Form 144
- ASND's page on the SEC website